Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
100 participants
OBSERVATIONAL
2024-12-05
2025-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Frequency of Glucose Monitoring in Labor
NCT06373432
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
NCT06643351
Daily Versus Every Other Day Glucose Monitoring in Gestational Diabetes Mellitus
NCT04857073
Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
NCT03007186
Pregnancy and Postpartum CGM in GDM
NCT07174245
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infrequent
Patients will undergo one fingerstick on admission for their labor process.
Fingerstick
fingersticks during their labor process
Frequent
Patients will undergo fingersticks every 4 hours in latent labor and 2 hour in active labor during their labor process.
Fingerstick
fingersticks during their labor process
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fingerstick
fingersticks during their labor process
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with singleton gestation presenting in labor or for induction
* Patients who had "good" glucose control and were A1GDM. Good Control;
* \- Patient with overall outpatient glucose average of less than 100
* \- No evidence of fetopathy, large for gestational age or polyhydramnios.
* \- Hgb A1c \<5.7
Exclusion Criteria
18 Years
51 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Icahn School of Medicine at Mount Sinai
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Owens
Maternal Fetal Medicine Fellow
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Owens, MD
Role: PRINCIPAL_INVESTIGATOR
Mount Sinai West
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mount Sinai West
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY-24-01116
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.